Original Article
Black Cohosh Hepatic Safety: Follow-Up of 107 Patients Consuming a Special Cimicifuga racemosa rhizome Herbal Extract and Review of Literature
Table 2
Follow up of patients assuming Cimicifuga.
| | Parameter | Values |
| | Physical examination | | | BMI | 28.5 (SD 0.71) | | Blood pressure | | | systolic | 125 (SD 7.07) | | diastolic | 75 (SD 21.21) | | Heart rate | 76.5 (SD 0.71) | |
Few patients (9/107) were suffering of minor complaints, that revalued after 1 month did not show any sign of liver disease | | Abdominal pain | 5 (4.6%) | | Paresthesias | 3 (2.8%) | | Fatigue | 2 (1.8%) | | Anorexia | 1 (0.9%) | | Myalgia | 1 (0.9%) | | Malaise | 1 (0.9%) | | Pruritus | 1 (0.9%) | | Fever | 0 | | Skin rash | 0 | | Jaundice | 0 | | Laboratory findings | | | Leukocyte total count | 4250 mm3 (SD 1060) | | Bilirubin | 0.75 mg dl−1 (SD 0.07) | | AST | 29.5 IU−1 (SD 10.61) | | ALT | 15.5 IU l−1 (SD 17.68) | | Alkaline Phosphatase | 135 U l−1 (SD 63.64) | | GGT | 28 U l−1 (SD 7.07) | | Albumin | 3.75 g dl−1 (SD 0.49) | | INR | 1 (SD 0.14) |
|
|
